Terms: = Thyroid cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
18 results:
1. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of the clinical utility of adhesion molecules in the management of thyroid nodules.
Rabi LT; Peres KC; Nascimento M; de Souza Teixeira E; de Freitas LLL; Barreto IS; Geraldo MV; Assumpção LVM; Máximo V; Tincani AJ; Bufalo NE; Ward LS
Sci Rep; 2023 Mar; 13(1):4069. PubMed ID: 36906717
[TBL] [Abstract] [Full Text] [Related]
3. Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
Kandeel A; Saied M; Aldaly M; Darwish H; Alsayed Y
Nucl Med Commun; 2021 Feb; 42(2):216-224. PubMed ID: 33165255
[TBL] [Abstract] [Full Text] [Related]
4. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
[TBL] [Abstract] [Full Text] [Related]
5. Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients.
Prpic M; Kruljac I; Kust D; Suton P; Purgar N; Bilos LK; Gregov M; Mrcela I; Franceschi M; Djakovic N; Frobe A
Radiol Oncol; 2019 Nov; 53(4):488-496. PubMed ID: 31747379
[TBL] [Abstract] [Full Text] [Related]
6. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer.
Abraham E; Roshan D; Tran B; Wykes J; Campbell P; Ebrahimi A
J Surg Oncol; 2019 Nov; 120(6):1016-1022. PubMed ID: 31452204
[TBL] [Abstract] [Full Text] [Related]
7. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary thyroid Carcinoma.
Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in thyroid Nodules.
Ahn SH; Park SY; Choi SI
Endocr Pathol; 2017 Dec; 28(4):332-338. PubMed ID: 28748505
[TBL] [Abstract] [Full Text] [Related]
9. Genomic profile of a Li-Fraumeni-like syndrome patient with a 45,X/46,XX karyotype, presenting neither mutations in TP53 nor clinical stigmata of Turner syndrome.
Basso TR; Villacis RA; Canto LM; Alves VM; Lapa RM; Nóbrega AF; Achatz MI; Rogatto SR
Cancer Genet; 2015 Jun; 208(6):341-4. PubMed ID: 25935441
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.
Barollo S; Pezzani R; Cristiani A; Redaelli M; Zambonin L; Rubin B; Bertazza L; Zane M; Mucignat-Caretta C; Bulfone A; Pennelli G; Casal Ide E; Pelizzo MR; Mantero F; Moro S; Mian C
Thyroid; 2014 May; 24(5):809-19. PubMed ID: 24295088
[TBL] [Abstract] [Full Text] [Related]
11. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases.
Jaso J; Chen L; Li S; Lin P; Chen W; Miranda RN; Konoplev S; Medeiros LJ; Yin CC
Hum Pathol; 2012 Sep; 43(9):1436-43. PubMed ID: 22406370
[TBL] [Abstract] [Full Text] [Related]
12. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract] [Full Text] [Related]
13. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract] [Full Text] [Related]
14. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000.
Chow SM; Law SC; Au SK; Mang O; Yau S; Yuen KT; Lau WH
Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):329-36. PubMed ID: 14524486
[TBL] [Abstract] [Full Text] [Related]
15. Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses.
Bovée JV; Sakkers RJ; Geirnaerdt MJ; Taminiau AH; Hogendoorn PC
J Clin Pathol; 2002 Mar; 55(3):226-9. PubMed ID: 11896078
[TBL] [Abstract] [Full Text] [Related]
16. Thimerosal increases the responsiveness of the calcium receptor in human parathyroid and rMTC6-23 cells.
Mihai R; Lai T; Schofield G; Farndon JR
Cell Calcium; 1999; 26(3-4):95-101. PubMed ID: 10598273
[TBL] [Abstract] [Full Text] [Related]
17. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance.
Müller CG; Bayley TA; Harrison JE; Tsang R
Thyroid; 1995 Apr; 5(2):81-7. PubMed ID: 7647577
[TBL] [Abstract] [Full Text] [Related]
18. Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1992 May; 168(5):260-9. PubMed ID: 1598660
[TBL] [Abstract] [Full Text] [Related]
